Related Experiment Video
Updated: Jul 16, 2026

Monocular Visual Deprivation and Ocular Dominance Plasticity Measurement in the Mouse Primary Visual Cortex
Published on: February 8, 2020
Bipolar disorder
Bruno Müller-Oerlinghausen1, Anne Berghöfer, Michael Bauer
1Department of Psychiatry, Research Group of Clinical Psychopharmacology, Freie Universität Berlin, Berlin, Germany.bmoe@zedat.fu-berlin.de
Insights
Bipolar disorder, a severe mood disorder, has high morbidity and suicide rates. Lithium salts are the primary long-term treatment for bipolar disorder, offering proven antisuicidal effects.
Area of Science:
- Psychiatry
- Neuroscience
- Mood Disorders
Background:
- Bipolar disorder (manic-depressive illness) is a common, severe, recurrent mood disorder with significant morbidity.
- Lifetime prevalence is 1.3-1.6%, with mortality rates 2-3 times higher than the general population.
- Suicide risk is substantial, with 10-20% of patients dying by suicide and nearly a third attempting it.
Purpose of the Study:
- To review the characteristics and treatment of bipolar disorder.
- To highlight the importance of long-term prophylactic treatment.
- To discuss the efficacy of different pharmacological interventions.
Main Methods:
- Review of existing literature on bipolar disorder.
- Analysis of prevalence, morbidity, and mortality data.
- Evaluation of pharmacological treatment options, including lithium, carbamazepine, and valproate.
Main Results:
- Bipolar disorder presents with diverse clinical manifestations, from hypomania to severe psychosis.
- Long-term prophylactic pharmacological treatment is essential due to high recurrence and suicide risks.
- Lithium salts are the first-line treatment, demonstrating significant antisuicidal effects.
- Carbamazepine and valproate are second-choice options with less robust evidence.
Conclusions:
- Bipolar disorder requires long-term management to mitigate recurrence and suicide risk.
- Lithium remains the gold standard for prophylactic treatment in bipolar disorder.
- Further research may be needed to strengthen evidence for second-line treatments.
Abstract:
Bipolar, or manic-depressive, disorder is a frequent, severe, mostly recurrent mood disorder associated with great morbidity. The lifetime prevalence of bipolar disorder is 1.3 to 1.6%. The mortality rate of the disease is two to three times higher than that of the general population. About 10-20% of individuals with bipolar disorder take their own life, and nearly one third of patients admit to at least one suicide attempt. The clinical manifestations of the disease are exceptionally diverse. They range from mild hypomania or mild depression to severe forms of mania or depression accompanied by profound psychosis. Bipolar disorder is equally prevalent across sexes, with the exception of rapid cycling, a severe and difficult to treat variant of the disorder, which arises mostly in women. Because of the high risk of recurrence and suicide, long-term prophylactic pharmacological treatment is indicated. Lithium salts are the first choice long-term preventive treatment for bipolar disorder. They also possess well documented antisuicidal effects. Second choice prophylactic treatments are carbamazepine and valproate, although evidence of their effectiveness is weaker.
Related Concept Videos
Interference and Diffraction
Photoreceptors and Visual Pathways
The Electrical Double Layer
Bipolar Disorder
Intellectual Disability
Learning Disabilities
Dyslexia
Dyslexia is a...

